메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

PRISM BioLab Achieved Initial Milestone and Receives the Mile…

TOKYO, Nov. 14, 2025 -- PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka; President and COO: Toichi Takino; hereinafter "Ono") have achieved the initial milestone in the drug discovery collaboration and PRISM has confirmed receipt of the milestone payment. PRISM and Ono have entered into a "Joint Research and Licensing Agreement" on April 25, 2024, (hereinafter "the Agreement") for drug discovery in the oncology field. Under this Agreement, PRISM received an u
- 김갑성 기자
- 2025-11-14 16:00
Smartee Demonstrates World-Class Manufacturing Capacity…

SHANGHAI, Nov. 14, 2025 -- Smartee Denti-Technology has showcased its world-class production system, designed to meet the increasing demand for its clear aligner products across the globe. With cutting-edge technology and robust manufacturing capabilities, Smartee supports its global brand expansion while serving orthodontic professionals in over 57 countries and regions. One of the key factors behind Smartee's success is its proprietary intelligent manufacturing system. Smartee launched China's first fully automated aligner production line in 2021, and with several years' cont
- 김갑성 기자
- 2025-11-14 14:44
Shangpu Group Issues Authoritative Market Position Stateme…

BEIJING, Nov. 14, 2025 -- Healthy food products grown in the konjac fields of Ankang, China, are gaining traction among international consumers, driven by Konjac Brother, a fast-growing Chinese food company committed to product innovation and health-focused foods. In a recent development, Shangpu Group, a leading China-based market research firm, released a specialized market position statement formally recognizing Konjac Brother as the "Pioneer of Xi'an Konjac Cold Noodles." This endorsement highlights the company's leadership in category innovation as it expands beyond its
- 김갑성 기자
- 2025-11-14 14:00
Herbalgy Unveils a New Campaign Featuring Cecilia Yeung in…

HONG KONG, Nov. 14, 2025 -- Herbalgy, Hong Kong's trusted pain management specialist, today unveils an inspiring new brand campaign that marks a significant milestone in the company's evolution. The campaign features an authentic conversation between Hong Kong's record-breaking high jump athlete Cecilia Yeung and Professor Wong Tin Chee, Herbalgy's founder, blending elite sports perspectives with professional pain management expertise. Download high-resolution images: https://shorturl.at/nMs45 Alongside the campaign, Herbalgy introduces two new innovations, the T
- 김갑성 기자
- 2025-11-14 09:00
Reimagining Child Safety in the Face of Coercive Control: Asia…

SYDNEY, Nov. 14, 2025 -- From 17–19 March 2026, leaders in domestic violence prevention, child protection, health, and family law will gather in Sydney for the Asia Pacific Coercive Control & Children Conference at the Roundhouse at the University of New South Wales. The event marks the 20th anniversary of the Safe & Together Model, a framework that has reshaped how systems around the world respond to domestic abuse and keep children safe with survivors. Over the past two decades, the Model's child-centred, survivor-aligned, and perpetrator-focused approach has helped t
- 김갑성 기자
- 2025-11-14 06:58
icotec Receives FDA Clearance for the CMORE® CT System, Exp…

ALTSTÄTTEN, Switzerland and BOSTON, Nov. 14, 2025 -- icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE® CT System for use in the cervicothoracic spine. The CMORE® (CT) System is an enhanced set of instruments and implants for posterior stabilization of the upper spine. The world's first spinal implants made of nonmetallic and radiolucent BlackArmor® technology now enable a full spectrum of treatment modalities in adjuvant tum
- 김갑성 기자
- 2025-11-14 00:19
LODD Completes First Flight of Hili - The UAE's First Hybrid Heavy Ca…

ABU DHABI, UAE, Nov. 13, 2025 -- LODD Autonomous successfully completed the first flight of Hili, the UAE's first hybrid vertical take-off and landing (VTOL) heavy-cargo aircraft designed, built, and tested in Abu Dhabi for the world. The historic event, held at LODD's flight test facility at Emirates Falcon Aviation in Al Ain, as part of Abu Dhabi Autonomous Week, represents a defining national milestone in the advancement of autonomous aviation and next-generation cargo logistics. The successful first flight of Hili marks a major engineering and operational achievement
- 김갑성 기자
- 2025-11-13 23:29
Datasea Reports First Quarter Gross Profit of $1.2 Million, a 4.9x In…

Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING, Nov. 13, 2025 -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a Nevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its unaudited financial results for its first fiscal quarter ended September 30, 2025. Additional information will also be set forth in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. First Quarter Fiscal 2026 Highlights
- 김갑성 기자
- 2025-11-13 22:31
The 19th China (Chongqing) Senior Citizen Expo concludes…

CHONGQING, China, Nov. 13, 2025 -- The 19th China (Chongqing) Senior Citizen Expo and the 1st Western International Conference on High-quality Development of Silver Economy, and the 6th China (Chongqing) Health Industry Expo (hereinafter referred to as the "Senior Citizen Expo") were successfully held at the Chongqing International Expo Center from November 7 to 9, 2025, guided by the China Association of Social Welfare and Senior Service and the China Silver Industry Association, and hosted by the Chongqing Pension Service Association, the China Chamber of International Commerce Ch
- 김갑성 기자
- 2025-11-13 22:07
LISCure Expands Global Partnerships for BBB Shuttle Platform 'E…

SEOUL, South Korea, Nov. 13, 2025 -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blood-brain barrier (BBB) shuttle platform, ExoPN-101. This marks LISCure's fourth MTA, further validating the technological innovation and commercial potential of the ExoPN-101 platform in the global market. ExoPN-101 is a next-generation BBB-penetrating delivery platform
- 김갑성 기자
- 2025-11-13 21:00

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-12-11_THU

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 11일 04시 00분